Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

Molindone chemical structure

IUPAC name
CAS number
ATC code


Chemical formula {{{chemical_formula}}}
Molecular weight 276.374 g/mol
Metabolism Hepatic
Elimination half-life 1.5 hours
Excretion Minor, renal and fecal
Pregnancy category
Legal status
Routes of administration Oral

Molindone is a therapeutic antipsychotic, used in the treatment of schizophrenia.[1] It works by blocking the effects of dopamine in the brain, leading to diminished psychoses. It is rapidly absorbed when taken by mouth.

Molindone is sold under the product name Moban.

Adverse effects[edit | edit source]

Main article: Typical antipsychotic

The side effect profile of molindone is similar to that of other typical antipsychotics. Unlike most antipsychotics, however, molindone use is associated with weight loss.[2][3]

See also[edit | edit source]

References[edit | edit source]

  1. molindone. (web) F.A. Davis Company. URL accessed on 2007-11-04.
  2. Bagnall A, Fenton M, Kleijnen J, Lewis R (2007). Molindone for schizophrenia and severe mental illness. Cochrane Database Syst Rev (1): CD002083.
  3. Allison DB, Mentore JL, Heo M, et al (1999). Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156 (11): 1686–96. Free full text

This page uses Creative Commons Licensed content from Wikipedia (view authors).
Community content is available under CC-BY-SA unless otherwise noted.